https://www.selleckchem.com/pr....oducts/cerivastatin-
3%, 0.001), and higher rates of cardiac comorbidities (39.5% vs. 18.5%, =0.02). Significant associations were not observed between GETA/ADDS status and airway support, 30-day readmission, fever, or pain medication in unadjusted or adjusted models. GETA patients had significantly increased length of stay (e =1.55, 95% confidence interval [CI]=1.11-2.18) after adjusting for ASA class, room time, anesthesia time, fever, and cardiac diagnosis. GETA patients also had increased room time (e =1.20, 95% CI=1.08-1.33) and anesthe
Aimer
Commentaire
Partagez
